Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur Rev Med Pharmacol Sci ; 27(21): 10255-10263, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-37975350

RESUMO

OBJECTIVE: The aim of this study was to predict the mechanism of Osteoking in preventing deep vein thrombosis (DVT) of the lower limb by network pharmacology and molecular docking. MATERIALS AND METHODS: The relevant active components and targets of Osteoking were collected through the TCMSP database, and the relevant disease targets of DVT were collected through the GeneCards, OMIM, and DisGeNET databases. The intersecting gene targets of Osteoking and DVT were obtained using Venny 2.1.0 software. PPI network construction and core target selection using Cytoscape 3.9.0 software. The Metascape database was used for GO and KEGG enrichment analysis of relevant targets. Finally, the molecular docking of the main active components and key targets was carried out. RESULTS: There are 361 potential targets and 71 core targets of Osteoking in preventing deep vein thrombosis of the lower limb. Signal pathways are involved in various diseases such as cancer, diabetic complications, atherosclerosis, and more. Some of the most common pathways include AGE-RAGE signaling pathway and Calcium signaling pathway. Molecular docking results showed that the main active components of Osteoking had relatively stable binding activities with the key targets. CONCLUSIONS: Osteoking can play a role through multiple targets and multiple signal pathways to prevent the formation of deep venous thrombosis of the lower limb after fracture.


Assuntos
Medicamentos de Ervas Chinesas , Trombose Venosa , Humanos , Simulação de Acoplamento Molecular , Extremidade Inferior , Sinalização do Cálcio , Trombose Venosa/tratamento farmacológico , Trombose Venosa/prevenção & controle
2.
J Dev Orig Health Dis ; 9(2): 191-197, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29141697

RESUMO

Macrosomia, not only is closely associated with short-term, birth-related problems, but also has long-term consequences for the offspring. We investigated the expression of long non-coding RNAs (lncRNAs) and messenger RNAs (mRNAs) in the placenta of macrosomia births using a microarray profile. The data showed that 2929 lncRNAs and 4574 mRNAs were upregulated in the placenta of macrosomia births compared with the normal birth weight group (fold change ⩾2.0, P<0.05), and 2127 lncRNAs and 2511 mRNAs were downregulated (fold change ⩾2.0, P<0.05). To detect the function of the differentially expressed lncRNAs and their possible relationship with the differentially expressed mRNAs, we also performed gene ontology analysis and pathway analysis. The results demonstrated that the PI3K-AKT signalling pathway, the mitogen-activated protein kinase (MAPK) signalling pathway, the focal adhesion pathway, the B cell receptor signalling pathway, and the protein processing in endoplasmic reticulum and lysosome pathway were significantly differentially expressed in the macrosomia placenta. Four lncRNAs were randomly chosen from the differentially expressed lncRNAs to validate the microarray data by quantitative polymerase chain reaction (qPCR). The qPCR results were consistent with the microarray data. In conclusion, lncRNAs were significantly differentially expressed in the placenta of macrosomia patients, and may contribute to the pathogenesis of macrosomia.


Assuntos
Macrossomia Fetal/genética , Macrossomia Fetal/metabolismo , Perfilação da Expressão Gênica/métodos , RNA Longo não Codificante/genética , RNA Mensageiro/genética , Adulto , Feminino , Macrossomia Fetal/patologia , Humanos , Gravidez , Análise Serial de Proteínas , RNA Longo não Codificante/biossíntese , RNA Mensageiro/biossíntese
3.
J Biol Regul Homeost Agents ; 30(2): 345-52, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27358120

RESUMO

This study was designed to evaluate the effect of miRNA acting in regulating multi-directional differentiation ability of mesenchymal stem cell in treatment of osteoporosis (OP), with the aim of finding a new idea and approach for clinical treatment of OP. Estrogen deficiency-induced OP mice model was established by means of ovariectomy (OVX). Additionally, a sham group was set up for control. Bone Marrow Mesenchymal Stem Cells (BMMSCs) of OVX group (O/BMMSCs) and BMMSCs of sham group (S/BMMSCs) were separately cultured. Then surface markers of BMMSCs were detected. Multi-directional differentiation ability was identified in the two groups by giving cells targeted induced stimulation. It was found that the bone trabecula, bone density and bone volume fraction of distal femoral metaphysis in the OVX group were much lower than those of the sham group. Moreover, trabecular bone space in the OVX group became larger; O/BMMSCs and S/BMMSCs both had normal expression of surface markers as well as potentials of osteogenic and adipogenic differentiation; O/BMMSCs had a weaker osteogenic capability but a stronger adipogenic capability than S/BMMSCs. All the findings suggest that the regulatory effect of miRNA on multi-directional differentiation ability plays a vital role in the treatment of OP, and there is a close correlation between them; deficiency or functional defect of BMMSCs can result in the occurrence of OP.


Assuntos
Células-Tronco Mesenquimais/citologia , MicroRNAs/fisiologia , Osteogênese , Osteoporose/terapia , Animais , Diferenciação Celular , Feminino , Camundongos , Camundongos Endogâmicos C57BL
4.
J Dev Orig Health Dis ; 4(6): 522-6, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24924231

RESUMO

The purpose of this study was to analyze the expression of the placenta-specific microRNA miR-517a in maternal serum and in placental tissue from low birth weight newborns and try to detect the effects of miR-517a expression on invasion potential of trophoblasts. Placental tissue and maternal serum were collected from both low birth weight newborns (n = 10) and normal birth weight newborns (n = 20). Expression of miR-517a was assessed in placenta and serum samples by real-time qRT-PCR. In addition, human trophoblast HTR8/SVneo cells were transfected with a miR-517a 2'-O-methyl oligonucleotide or a negative control RNA, and invasion was measured using transwell migration assays. Expression of miR-517a was significantly increased in placentas from low birth weight newborns (61.79 ± 23.06) in comparison with those of normal birth weight newborns (5.01 ± 1.97; P < 0.05). The expression of miR-517a was also increased in maternal serum isolated from the low birth weight newborn (25.78 ± 8.69) compared with the normal birth weight newborn (3.21 ± 1.07; P < 0.05). Overexpression of miR-517a significantly inhibited invasion of HTR8/SVneo cells (P < 0.05). These data indicate that miR-517a overexpression could potentially lead to low birth weight, likely through the inhibition of trophoblast invasion.

5.
Placenta ; 33(9): 712-6, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22770822

RESUMO

PURPOSE: This study investigated the role and mechanism of Cdc42 in Endothelin-1 (ET-1)-induced trophoblast cell migration. METHODS: We examined ET-1-mediated stimulation of trophoblast migration with HTR-8/SVneo cells. Cdc42 activation was measured after ET-1 treatment of HTR-8/SVneo cells. To determine the ET receptor subtype involved in ET-1-mediated Cdc42 activation, experiments were performed in the presence of ET(A) and ET(B) receptor antagonists. Finally, using siRNA we knocked down the expression of Cdc42 to examine the involvement of Cdc42 in the regulation of ET-1-stimulated trophoblast cell migration. RESULTS: ET-1 was shown to have a dose-dependent effect on trophoblast migration. At low concentrations of ET-1 (0.1 nmol/L) ET-1 had a stimulatory effect on cell migration. ET-1 (10 nmol/L) increased HTR-8/svneo cell migration index by 2.5 fold. ET-1 (10 nmol/L) elevated protein level and activity of Cdc42. ET-1 induced activation of Cdc42 GTPase was mediated by both ET(A) and ET(B). ET-1-induced cell migration was shown to be inhibited by Cdc42 siRNA.The inhibition was not mitigated by the addition of ET-1, suggesting that Cdc42 plays an important role in trophoblast migration and is obligatory for ET-1 action. CONCLUSIONS: ET-1 stimulates EVT migration through Cdc42 activation.


Assuntos
Movimento Celular/efeitos dos fármacos , Endotelina-1/farmacologia , Trofoblastos/fisiologia , Proteína cdc42 de Ligação ao GTP/fisiologia , Linhagem Celular , Linhagem Celular Transformada , Relação Dose-Resposta a Droga , Antagonistas do Receptor de Endotelina A , Antagonistas do Receptor de Endotelina B , Feminino , Humanos , RNA Interferente Pequeno/farmacologia , Trofoblastos/efeitos dos fármacos , Proteína cdc42 de Ligação ao GTP/antagonistas & inibidores
6.
J Int Med Res ; 39(6): 2344-51, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22289553

RESUMO

This prospective study evaluated the short-term outcomes of 16 neonates undergoing single congenital omphalocele repair. Parents made informed choices for their baby to receive either immediate repair (IR group, n = 8) or repair ≥ 3 h after delivery (control group, n = 8). All babies were delivered by elective caesarian section. Babies in the two groups were matched one-to-one according to their birth weight, bulging volume and gestational age. Short-term outcomes included the incidence of infection and the lengths of stay in the neonatal intensive care unit (NICU) and in the hospital. Compared with the control group, the IR group showed a significantly lower incidence of infection, shorter surgical duration, shorter NICU stay, less time on total parenteral nutrition, less time to total enteral nutrition and shorter length of hospital stay. Immediate repair significantly improved the short-term neonatal outcomes of congenital omphalocele in China.


Assuntos
Hérnia Umbilical/cirurgia , Cicatrização , Estudos de Casos e Controles , China , Humanos , Recém-Nascido , Complicações Pós-Operatórias/etiologia , Análise de Sobrevida , Fatores de Tempo , Resultado do Tratamento
7.
Chin Med J (Engl) ; 114(4): 344-7, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11780450

RESUMO

OBJECTIVE: To provide epidemiological data for revising the diagnostic criteria of neonatal hyperbilirubinemia in China. METHODS: A survey was performed among full-term infants in multiple centers throughout the country. From less than 24 hours after birth, the infants' bilirubin levels were measured every day until the peak level fell to less than 68.4 mumol/L. Auditory brainstem responses were assessed in 56 infants randomly chosen from those with serum bilirubin levels of higher than 220.5 mumol/L. RESULTS: Jaundice in most infants was detected at 2-3 days after birth. The bilirubin level usually reached a peak level of 204 +/- 54.69 mumol/L at 5 days after birth and then fell. Among the 875 infants, the serum bilirubin levels in 34.4% of neonates were higher than 220.5 mumol/L. The mean serum bilirubin level of the infants during the first week after birth varied with geography (P < 0.001) and season (P < 0.001). The serum bilirubin level was significantly associated with gestation age (P < 0.01), delivery method (P < 0.01), weight loss (P < 0.001), and PCV elevation (P < 0.001) during the first three days after birth. CONCLUSIONS: The start time of neonatal jaundice was similar to that reported elsewhere, but the mean peak level in our study was higher than the reported. It is suggested that the diagnostic criteria for neonatal hyperbilirubinemia in China should be strict.


Assuntos
Icterícia Neonatal/epidemiologia , Bilirrubina/sangue , China/epidemiologia , Humanos , Recém-Nascido , Icterícia Neonatal/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...